Trial Profile
Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2014
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Corneal injuries; Dry eyes
- Focus Therapeutic Use
- Sponsors Allergan
- 22 May 2014 New trial record
- 19 Dec 2011
- 13 Jan 2009